Marks Group Wealth Management Inc Has $1.14 Million Holdings in Danaher Co. (NYSE:DHR)

Marks Group Wealth Management Inc boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 6.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,972 shares of the conglomerate’s stock after purchasing an additional 312 shares during the period. Marks Group Wealth Management Inc’s holdings in Danaher were worth $1,141,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of DHR. FMR LLC increased its stake in shares of Danaher by 15.8% in the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after buying an additional 3,217,631 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Danaher by 3.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock worth $1,417,342,000 after acquiring an additional 148,251 shares during the last quarter. Fisher Asset Management LLC increased its position in Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock valued at $1,265,725,000 after acquiring an additional 116,299 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Danaher by 17.6% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares during the last quarter. Finally, Montrusco Bolton Investments Inc. lifted its position in shares of Danaher by 0.6% during the fourth quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate’s stock worth $382,936,000 after purchasing an additional 9,942 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on DHR shares. Jefferies Financial Group lowered their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Citigroup lowered their target price on Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research note on Thursday, January 30th. Stephens reaffirmed an “overweight” rating and set a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. JPMorgan Chase & Co. lowered their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Stock Performance

Shares of Danaher stock opened at $202.22 on Thursday. The stock’s fifty day simple moving average is $231.17 and its 200 day simple moving average is $250.62. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The company has a market capitalization of $146.06 billion, a PE ratio of 38.30, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a 12 month low of $196.80 and a 12 month high of $281.70.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the company earned $2.09 EPS. On average, research analysts predict that Danaher Co. will post 7.67 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.53%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is currently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.